Persium Advisors’s Inhibrx INBX Stock Holding History

Persium Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$488K	Hold	4,875	–	–	0.26%	53
2026 Q2	$462K	Buy	+4,875	New	+$488K	0.3%	53

Other funds holding INBX

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Persium Advisors's INBX Position: Q3 2026 in Review

Persium Advisors held its Inhibrx (INBX) position steady in Q3 2026 at 4,875 shares worth $488K. The position accounts for 0.26% of the portfolio, ranked #53.

Persium Advisors first reported a position in INBX in Q2 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

Persium Advisors held 4,875 shares of Inhibrx worth $488K as of Q3 2026.
Persium Advisors left its Inhibrx share count unchanged in Q3 2026.
Inhibrx made up 0.26% of Persium Advisors's portfolio in Q3 2026, its #53 holding.
Persium Advisors first reported a position in Inhibrx in Q2 2026 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Persium Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.